Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab183060-100μg
|
100μg |
10
|
$59.90
|
|
|
Ab183060-1mg
|
1mg |
4
|
$289.90
|
|
|
Ab183060-5mg
|
5mg |
1
|
$749.90
|
|
|
Ab183060-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,189.90
|
|
Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Inolimomab (anti-IL2RA) - Primary antibody, specific to IL2RA, Human IgG1, ANTAGONIST of Interleukin-2 receptor alpha chain antagonist |
|---|---|
| Synonyms | CD25 antibody | IDDM10 antibody | IL 2 RA antibody | IL 2 receptor subunit alpha antibody | IL 2R alpha chain antibody | IL 2R subunit alpha antibody | IL-2 receptor subunit alpha antibody | IL-2-RA antibody | IL-2R subunit alpha antibody | IL2 RA antibod |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | IL2RA |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | ANTAGONIST |
| Mechanism of action | ANTAGONIST of Interleukin-2 receptor alpha chain antagonist |
| Product Description |
Inolimomab (anti-IL2RA) is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab (anti-IL2RA) improves the survival rate in the early research of treating acute graft-versus-host disease (aGVHD). |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 145.34 kDa |
| Purification Method | Protein A purified |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 152981-31-2 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Inolimomab (anti-IL2RA) (Ab183060) - Flow Cytometry
Flow Cytometry analysis of unstimulated (left) or 500 ng/mL Ionomycin (I139530) and 10 ng/mL PMA (P408905) co-stimulated (right) Jurkat cells labelling IL2RA (red) with Inolimomab (anti-IL2RA) (Ab183060) at 0.1 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Inolimomab (anti-IL2RA) (Ab183060) - ELISA
Immobilized Recombinant Human CD25/IL-2R alpha Protein (rp169618) at 1.0 μg/mL can bind Inolimomab (anti-IL2RA) (Ab183060) with the EC
₅₀
of 4.70 ng/mL.
Inolimomab (anti-IL2RA) (Ab183060) - SEC
The purity of Inolimomab (anti-IL2RA) (Ab183060) is more than 95% verified by HPLC.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 19, 2024 | Ab183060 | |
| Certificate of Analysis | Jun 19, 2024 | Ab183060 | |
| Certificate of Analysis | Jun 19, 2024 | Ab183060 |
Starting at $99.90
Starting at $16.90
Starting at $49.90
Starting at $59.90